Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021 ; volume:20 ; number:1 ; day:1 ; month:10 ; year:2023 ; pages:1-6 ; date:12.2023
Harm reduction journal ; 20, Heft 1 (1.10.2023), 1-6, 12.2023
- Urheber
-
Martinez, Anthony
Khan, Tipu
Dylla, Douglas E.
Marcinak, John
Collins, Michelle
Saget, Brad
Conway, Brian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-023-00874-y
- URN
-
urn:nbn:de:101:1-2024020710451905007316
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martinez, Anthony
- Khan, Tipu
- Dylla, Douglas E.
- Marcinak, John
- Collins, Michelle
- Saget, Brad
- Conway, Brian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection